Merck (MRK) Oct. Call Options See Massive Volume Spike
June 18, 2013
Medtronic Saga: Corrupt Science, Belated Warning
June 18, 2013
from YCharts
Secrets to Making Money in PG, MRK, GILD and F
June 18, 2013
In a ruling that is likely to have a far-reaching impact on the pharmaceutical industry, the Supreme Court permitted antitrust scrutiny of reverse pay settlements used between brand name drug makers... Read More
from Forbes Real Time
Trade Flow Analysis for Merck & (MRK)
June 18, 2013
from AVAFIN
Pharma Stocks: Court Ruling's Real Meaning
June 17, 2013
from YCharts
Worst Performing Dow Component: Pfizer
June 17, 2013
New York, June 17th (TradersHuddle.com) - The Dow Jones Industrial Average is higher trading at 15232, which represents 1.07% versus its previous trading session close, with only two of its components... Read More
from TradersHuddle.com
Secrets to Making Money in MRK, GE, MYGN and INTC
June 17, 2013
from PR Newswire
Merck is Near a Key Support Area
June 17, 2013
New York, June 17th (TradersHuddle.com) - Shares of Merck & Co. Inc. ( NYSE:MRK ) are trading very close to calculated support at $46.49 with price action closing at just $47.95 and placing the stock... Read More
from TradersHuddle.com
Merck Plans To Cut Jobs (MRK)
June 14, 2013
Pharmaceutical company Merck & Co., inc. (MRK) is planning to cut jobs and make structural changes to the organization of its research and development division. The New Jersey-based company is... Read More
from Dividend Daily
Friday's ETF with Unusual Volume: XPH
June 14, 2013
The SPDR S&P Pharmaceuticals ETF (XPH) is seeing unusually high volume in afternoon trading Friday, with over 119,000 shares traded versus three month average volume of about 40,000. Shares of XPH were... Read More
category
ETFs
from ETF Channel
Final Trade: Your First Move for Monday, June 17
June 14, 2013
from CNBC.com News
Once again, Eli Lilly has suffered a setback trying to find a useful drug to combat Alzheimer’s. Last year, a pair of late-stage trials for an injectable drug called solanezumab failed to meet primary... Read More
from Forbes Real Time
Merck Is Close to Resistance
June 14, 2013
New York, June 14th (TradersHuddle.com) - Shares of Merck & Co. Inc. ( NYSE:MRK ) are trading very close to calculated resistance at $50.16. The stock ended the trading session at just $47.90, which is... Read More
from TradersHuddle.com
from AVAFIN
Bio-Wire Equity Surveillance – Closing Bell 6/13/2013
June 13, 2013
Thursday, June 13th, 2013 DJIA: +1.21% to 15,176.08 S&P 500: +1.48% to 1,636.36 NASDAQ: +1.32% to 3,445.37 NYSE Arca – Pharma Index: +1.05% to 429.90 Big pharma (Mkt Cap $10 B+) +1.03% Mid-sized pharma... Read More
from Bio-Wire.Com
Knucklehead Buybacks; How to Find Smart Ones
June 13, 2013
from YCharts
Merck (MRK) Crosses Pivot Point Support at $46.95
June 13, 2013
All Penny Stocks.com News: Nuvi Fruits Signs Agreement to Use Dehydration Technology of EnWave Corp
June 13, 2013
The Straight Truth, Investing in MRK, PBR, ITUB and NOK
June 13, 2013
Several securities within the pharmaceutical sector have experienced notable spikes in short interest lately, despite their technical prowess...( Read More ) Read More
category
MRK
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
